BiotechTube
Home/Pasithea Therapeutics/Tiago Reis Marques, MD, PhD
TR

Tiago Reis Marques, MD, PhD

Chief Executive Officer

Pasithea Therapeutics

Therapeutic Areas

NeurologyPsychiatryRASopathies

Pasithea Therapeutics Pipeline

DrugIndicationPhase
PAS-004 (MEK Inhibitor)Neurofibromatosis Type 1 (NF1)Preclinical
MEK Inhibitor ProgramAmyotrophic Lateral Sclerosis (ALS)Discovery

Leadership Team at Pasithea Therapeutics

PL
Professor Lawrence Steinman, MD, PhD
Chairman
GC
Graeme Currie, PhD
Chief Development Officer
DS
Daniel Schneiderman
Chief Financial Officer
View full Pasithea Therapeutics profile